(19)
(11)
EP 0 701 401 A1
(12)
(43)
Date of publication:
20.03.1996
Bulletin 1996/12
(21)
Application number:
94914075.0
(22)
Date of filing:
07.04.1994
(51)
International Patent Classification (IPC):
C12N
15/
09
( . )
C07H
17/
00
( . )
C12N
5/
10
( . )
C12N
15/
861
( . )
A61K
48/
00
( . )
A61K
38/
00
( . )
C07K
14/
785
( . )
C12N
7/
00
( . )
C12P
21/
02
( . )
C12R
1/
91
( . )
(86)
International application number:
PCT/US1994/003831
(87)
International publication number:
WO 1994/023582
(
27.10.1994
Gazette 1994/24)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
08.04.1993
US 19930044406
(71)
Applicants:
GENETIC THERAPY, INC.
Gaithersburg, MD 20878 (US)
UNIVERSITY OF CINCINNATI CHILDREN'S HOSPITAL
Cincinnati, OH 45229-2899 (US)
(72)
Inventors:
TRAPNELL, Bruce
Kensington, MD 20895 (US)
WHITSETT, Jeffrey
Cincinnati, OH 45230 (US)
(74)
Representative:
LOUIS, PÖHLAU, LOHRENTZ & SEGETH
Postfach 3055
D-90014 Nürnberg
D-90014 Nürnberg (DE)
(54)
ADENOVIRAL VECTORS INCLUDING DNA ENCODING LUNG SURFACTANT PROTEIN